Aravive, Inc. — Form D

Aravive, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2013-01-28. The offering totals $20.5M, of which $8.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Kevin JohnsonDirectorSan Diego, CA
JEFFREY CLELANDDirectorBALTIMORE, MD
JEFFREY CLELANDExecutive OfficerBALTIMORE, MD
Shahzad MalikDirectorSan Diego, CA
Michael DybbsDirectorHalf Moon Bay, CA
Srinivas AkkarajuDirectorPalo Alto, CA
Fredric N EshelmanDirectorDurham, NC
Fredric N EshelmanExecutive OfficerDurham, NC
MICHAEL W ROGERSDirectorNEW YORK, NY
Francesco De RubertisDirectorCharlottesville, VA
Anthony SunDirectorApex, NC
Jay ShepardDirectorDallas, TX
Rudy N HowardExecutive OfficerHouston, TX
Sigurd C KirkDirectorHouston, TX
Peter TC HoDirectorHouston, TX
Robert B GellerExecutive OfficerHouston, TX
Gail McIntyreDirectorHouston, TX
Gail McIntyreExecutive OfficerHouston, TX
Leonard Scott DoveExecutive OfficerHouston, TX
Eric B ZhangDirectorHouston, TX
Amato B GiacciaDirectorHouston, TX
John A HohneckerDirectorHouston, TX
Volker SchellenbergerDirectorSouth San Francisco, CA
Joshua BrummExecutive OfficerWaltham, MA
Edmon JenningsDirectorRedwood City, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2022-10-28D$41.6M$41.6M
2014-02-20D$55.0M$55.0M
2014-02-19D$10.0M$10.0M
2013-10-11D$10.0M$10.0M
2013-07-22D$12.5M$12.5M
2013-01-28D$4.6M$4.6M
2011-03-09D$21.1M$14.4M

More